WDNA: WisdomTree BioRevolution Fund - MutualFunds.com
Continue to site >
Trending ETFs

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

WisdomTree BioRevolution ETF

WDNA - Snapshot

Vitals

  • YTD Return N/A
  • 3 Yr Annualized Return N/A
  • 5 Yr Annualized Return N/A
  • Net Assets $2.67 M
  • Holdings in Top 10 12.9%

52 WEEK LOW AND HIGH

$25.92
$24.98
$26.98

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.45%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover N/A

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) N/A
  • IRA N/A

Fund Classification


Compare WDNA to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$236.04

-0.40%

$51.72 B

0.91%

$2.16

9.42%

0.32%

$132.33

+0.14%

$27.88 B

1.33%

$1.76

18.27%

0.12%

$110.44

+0.29%

$19.01 B

-

$0.00

11.72%

0.76%

$128.20

+0.02%

$17.94 B

1.11%

$1.43

14.56%

0.10%

$256.66

+0.09%

$17.94 B

1.11%

$2.85

16.10%

0.10%

WDNA - Profile

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    WisdomTree BioRevolution Fund
  • Fund Family Name
    Wisdom
  • Inception Date
    Jun 01, 2021
  • Shares Outstanding
    100000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Marlene Walker-Smith

Fund Description

The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.


WDNA - Performance

Return Ranking - Trailing

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -80.6% 33.2% N/A
1 Yr N/A -28.3% 121.6% N/A
3 Yr N/A* 6.8% 50.0% N/A
5 Yr N/A* 5.0% 42.5% N/A
10 Yr N/A* 9.3% 19.7% N/A

* Annualized

Return Ranking - Calendar

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -49.7% 21.5% N/A
2017 N/A -59.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A

Total Return Ranking - Trailing

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -80.5% 32.0% N/A
1 Yr N/A -30.3% 121.6% N/A
3 Yr N/A* -14.1% 50.0% N/A
5 Yr N/A* -3.7% 42.5% N/A
10 Yr N/A* 9.3% 19.7% N/A

* Annualized

Total Return Ranking - Calendar

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -25.3% 22.2% N/A
2017 N/A -10.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A

WDNA - Holdings

Concentration Analysis

WDNA Category Low Category High WDNA % Rank
Net Assets 2.67 M 2.67 M 51.7 B 100.00%
Number of Holdings 116 11 506 25.43%
Net Assets in Top 10 345 K 2.19 K 19.3 B 87.93%
Weighting of Top 10 12.94% 7.2% 94.7% 99.14%

Top 10 Holdings

  1. Agenus Inc 1.45%
  2. Biogen Inc 1.44%
  3. Eli Lilly and Co 1.38%
  4. PerkinElmer Inc 1.30%
  5. Illumina Inc 1.28%
  6. Editas Medicine Inc 1.24%
  7. Agilent Technologies Inc 1.22%
  8. Alexion Pharmaceuticals Inc 1.21%
  9. Thermo Fisher Scientific Inc 1.21%
  10. Takara Bio Inc 1.20%

Asset Allocation

Weighting Return Low Return High WDNA % Rank
Stocks
100.00% 85.95% 104.58% 24.14%
Preferred Stocks
0.00% 0.00% 5.23% 85.34%
Other
0.00% -26.05% 9.11% 83.62%
Convertible Bonds
0.00% 0.00% 0.03% 83.62%
Cash
0.00% -0.13% 8.88% 92.24%
Bonds
0.00% 0.00% 17.12% 83.62%

Stock Sector Breakdown

Weighting Return Low Return High WDNA % Rank
Healthcare
85.89% 62.01% 100.00% 98.71%
Basic Materials
8.53% 0.00% 8.53% 0.43%
Consumer Defense
3.83% 0.00% 29.47% 1.29%
Energy
0.93% 0.00% 0.93% 0.43%
Utilities
0.83% 0.00% 0.83% 0.43%
Technology
0.00% 0.00% 19.13% 86.64%
Real Estate
0.00% 0.00% 6.19% 84.05%
Industrials
0.00% 0.00% 7.02% 85.34%
Financial Services
0.00% 0.00% 2.61% 90.09%
Communication Services
0.00% 0.00% 7.81% 85.34%
Consumer Cyclical
0.00% 0.00% 18.45% 85.78%

Stock Geographic Breakdown

Weighting Return Low Return High WDNA % Rank
US
85.96% 56.42% 104.03% 58.62%
Non US
14.04% 0.00% 40.85% 38.79%

WDNA - Expenses

Operational Fees

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.45% 0.08% 2.91% 66.08%
Management Fee 0.45% 0.00% 1.25% 16.48%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 3.00% 256.00% N/A

WDNA - Distributions

Dividend Yield Analysis

WDNA Category Low Category High WDNA % Rank
Dividend Yield 0.00% 0.00% 0.69% 86.64%

Dividend Distribution Analysis

WDNA Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

WDNA Category Low Category High WDNA % Rank
Net Income Ratio N/A -2.54% 1.92% N/A

Capital Gain Distribution Analysis

WDNA Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Dividend Payout History

View More +

WDNA - Fund Manager Analysis

Managers

Marlene Walker-Smith


Start Date

Tenure

Tenure Rank

Jun 01, 2021

0.08

0.1%

Ms. Marlene Walker-Smith, a Director, Co-Head of Equity Index Portfolio Management, has been with Mellon Investments Corporation since 1995. Ms. Walker-Smith leads a team of portfolio managers covering domestic and international index portfolios, as well as corporate actions. Previously, she served as an equity index portfolio manager and equity trader forMellon Investments Corporation. Prior to joining the firm, Ms. Walker Smith was a trader for Banc One Investment Advisors Corporation and a brokerage services manager for Mid Atlantic Capital Corporation. She has been in the investment industry since 1990. Ms. Walker-Smith earned an MBA in finance from the University of Pittsburgh and a BA in history and Russian from Washington & Jefferson College.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 23.81 6.75 1.21